eicosapentaenoic acid ethyl ester has been researched along with omacor in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calder, PC; Cawood, AL; Ding, R; Gallagher, PJ; Grimble, RF; Gudmundsen, O; Napper, FL; Payne, SP; Shearman, CP; Vige, R; Ward, MJ; Williams, JA; Ye, S; Young, RH | 1 |
| Zampelas, A | 1 |
| Gamoh, S; Haque, AM; Hashimoto, M; Katakura, M; Shahdat, H; Shido, O; Tanabe, Y; Tozawa, R | 1 |
| Hashimoto, M; Hossain, S; Inoue, T; Katakura, M; Shido, O; Tanabe, Y; Tsuchikura, S | 1 |
| Weintraub, HS | 1 |
| Kedia, AW; Lynch, E | 1 |
| Anzalone, D; Backes, J; Catini, J; Hilleman, D | 1 |
3 review(s) available for eicosapentaenoic acid ethyl ester and omacor
| Article | Year |
|---|---|
Isosapent ethyl (Vascepa) for severe hypertriglyceridemia.
Topics: Animals; Clinical Trials as Topic; Dietary Supplements; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Humans; Hypertriglyceridemia; Severity of Illness Index; Triglycerides | 2013 |
Overview of prescription omega-3 fatty acid products for hypertriglyceridemia.
Topics: Cholesterol, LDL; Dietary Supplements; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Humans; Hypertriglyceridemia; Hypolipidemic Agents | 2014 |
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia.
Topics: Adult; Biological Availability; Cholesterol, LDL; Diacylglycerol O-Acyltransferase; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Esters; Fatty Acids, Omega-3; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipogenesis; Lipoprotein Lipase; Lipoproteins, VLDL; Liver; Oxidation-Reduction; Triglycerides | 2016 |
1 trial(s) available for eicosapentaenoic acid ethyl ester and omacor
| Article | Year |
|---|---|
Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Capsules; Carotid Artery Diseases; Chi-Square Distribution; Cytokines; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Eicosapentaenoic Acid; Endarterectomy, Carotid; England; Female; Foam Cells; Gene Expression Regulation; Humans; Inflammation; Inflammation Mediators; Male; Matrix Metalloproteinases; Middle Aged; Phospholipids; Preoperative Care; RNA, Messenger; Rupture, Spontaneous; T-Lymphocytes; Treatment Outcome | 2010 |
4 other study(ies) available for eicosapentaenoic acid ethyl ester and omacor
| Article | Year |
|---|---|
Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.
Topics: Administration, Oral; Capsules; Carotid Artery Diseases; Dietary Supplements; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Endarterectomy, Carotid; Foam Cells; Gene Expression Regulation; Humans; Inflammation; Inflammation Mediators; Matrix Metalloproteinases; Phospholipids; Preoperative Care; Rupture, Spontaneous; T-Lymphocytes; Treatment Outcome | 2010 |
Protective effects of prescription n-3 fatty acids against impairment of spatial cognitive learning ability in amyloid β-infused rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cerebral Cortex; Cerebral Ventricles; Cognition Disorders; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Fatty Acids; Fatty Acids, Omega-3; Hippocampus; Lipid Peroxides; Male; Maze Learning; Rats; Rats, Wistar; Reactive Oxygen Species | 2011 |
Prescription n-3 fatty acids, but not eicosapentaenoic acid alone, improve reference memory-related learning ability by increasing brain-derived neurotrophic factor levels in SHR.Cg-Lepr(cp)/NDmcr rats, a metabolic syndrome model.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Fatty Acids; Fatty Acids, Omega-3; Hippocampus; Lipid Peroxides; Male; Maze Learning; Memory; Metabolic Syndrome; Rats; Rats, Inbred SHR | 2013 |
Effects of switching from omega-3-acid ethyl esters to icosapent ethyl in a statin-treated patient with elevated triglycerides.
Topics: Adult; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Esters; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertriglyceridemia; Hypothyroidism; Lipids; Male; Risk Factors | 2015 |